Exploring What’s Possible for HS TreatmentOctober 22nd 2022
At the 2022 Fall Clinical Dermatology Conference, Joslyn R. Sciacca Kirby, MD, MS, MEd, and Raj Chovatiya, MD, PhD, discussed how there is a large unmet need for hidradenitis suppurativa treatment and what future treatment could look like.
Consistent Efficacy With a Durable Safety Profile Through 5 Years and a Growing Body of Real-World EvidenceOctober 22nd 2022
At the 2022 Fall Clinical Dermatology Conference in Las Vegas, Aaron S. Farberg, MD, shares data on the treatment of plaque psoriasis using tildrakizumab-asmn.
JAK Inhibitors for the Management of Atopic DermatitisOctober 21st 2022
Lisa Swanson, MD, FAAD, and James Q. Del Rosso, DO, FAOCD, FAAD, gave an in-depth discussion on Janus kinase (JAK) inhibitors for the management of atopic dermatitis at the 2022 Fall Clinical Dermatology Conference.
Heather Ivy, DO, Explains Why She is Excited for Fall ClinicalOctober 21st 2022
As the 2022 Fall Clinical Dermatology Conference begins this week, Heathy Ivy, DO, regional medical director for LaserAway in Atlanta, Georgia, shares why she is looking forward to attending Fall Clinical.
Raj Chovatiya, MD, PhD, Gets Excited About Presenting at Fall Clinical 2022October 20th 2022
Raj Chovatiya, MD, PhD, assistant professor of dermatology and Medical Director, Center for Eczema and Itch and Medical Director, Clinical Trials Unit at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, shares highlights from his upcoming presentations at Fall Clinical in Las Vegas, Nevada, October 20-23, 2022.
Botulinum Type A: Key Clinical PostulatesOctober 23rd 2021
Botulinum type A injections are widely used across the dermatology and aesthetic medicine specialties. At the Fall Clinical Dermatology Conference 2021, Mark S Nestor, MD, PhD, highlights how to optimize the neurotoxin to improve patient care.